131I相关唾液腺炎的炎症分级及内镜治疗

doi:10.19723/j.issn.1671-167X.2020.03.029

摘要/Abstract

摘要：

目的结合唾液腺造影及内镜表现对¹³¹I相关唾液腺炎进行炎症分级,评估分析内镜治疗的疗效。方法收集2012年11月至2018年10月间在北京大学口腔医院进行唾液腺内镜检查与治疗的¹³¹I相关唾液腺炎患者的临床及影像学资料,分析唾液腺造影与内镜表现的特点并进行炎症分级。根据病变程度,采取内镜下生理盐水与地塞米松混合液灌洗、机械扩张等治疗,术后进行随访。结果 42例¹³¹I相关唾液腺炎患者中,男性5例、女性37例,男女比例为1 ∶7.4,症状为唾液腺区反复肿胀、疼痛或口干等。腮腺造影主要表现为一处或多处导管狭窄,部分病例分支导管未显影。唾液腺内镜主要表现为导管不同程度狭窄,可见分支导管闭锁。根据腮腺造影及内镜所见分为3级:(1)轻度炎症:主导管存在狭窄和扩张,但0.9 mm内镜可通过;(2)中度炎症:主导管存在一处重度狭窄,内镜不能直接通过;(3)重度炎症:主导管存在2处以上重度狭窄、弥漫性狭窄或导管闭锁。33例(65侧)¹³¹I相关唾液腺炎患者的腮腺同时接受唾液腺造影与内镜检查,其中轻度炎症8侧,中度炎症23侧,重度炎症34侧。内镜治疗后经3~72个月随访,效果评价为显效22侧,缓解22侧,无效19侧,失访2侧,总有效率为69.8%。结论¹³¹I相关唾液腺炎的临床、腮腺造影以及唾液腺内镜表现具有明确的特点,据此我们提出¹³¹I相关唾液腺炎炎症严重程度的分级标准。唾液腺内镜技术可以明显缓解¹³¹I相关唾液腺炎患者的主观临床症状,对于早期病变效果更佳。

关键词: 唾液腺内镜, 唾液腺炎, 碘放射性同位素, 诊断, 治疗结果

Abstract:

Objective: To investigate the inflammation grading of¹³¹I radioiodine-induced sialadenitis based upon sialoendoscopic and sialographic appearances, and to evaluate the results of sialoendoscopic intervention.Methods: The patients diagnosed with¹³¹I radioiodine-induced sialadenitis and underwent sialoendoscopic exploration and intervention procedures in Peking University Hospital of Stomatology from Nov. 2012 to Oct. 2018 were included in this study. The appearances of sialogaphy and sialoendoscopy were analyzed and classified. The treatment options included irrigation with saline and dexamethasone and mechanical dilatation by sialoendoscope. The patients were followed up after treatment.Results: Forty-two patients with¹³¹I radioiodine-induced sialadenitis were included. There were 5 males and 37 females, with a male-to-female ratio of 1 ∶7.4. Symptoms included recurrent swelling and pain in the parotid glands, and dry mouth. Sialography showed stenosis in the main duct,and in some cases nonvisua-lization of the branches. Sialoendoscopy showed narrowing of the main duct, and the branch duct atresia was seen. The appearances of sialogaphy and sialoendoscopy were analyzed and classified into 3 groups: (1) Mild inflammation: stenosis and ectasia occurred in the main duct, whereas the 0.9 mm sialoendoscope could pass through easily. (2) Moderate inflammation: one point of severe stricture could be seen in the main duct where 0.9 mm sialoendoscope could not be passed through. (3) Severe inflammation: two points or more of severe strictures or diffused strictures occurred in the main duct. Thirty-three patients with 65 affected glands were examined by both sialography and sialoendoscopy. Eight glands were classified as mild inflammation, 23 glands moderate inflammation, and 34 glands severe inflammation. The duration of follow-up ranged from 3-72 months. The clinical results were evaluated as good in 22 glands, fair in 22 glands, and poor in 19 glands, with an overall effective rate of 69.8% (44/63).Conclusion: The clinical, sialographic and sialoendoscopic appearances of¹³¹I radioiodine-induced sialadenitis showed their characteristics. We proposed an inflammation grading standard for the¹³¹I radioiodine-induced sialadenitis based on the appearances of sialography and sialoendoscopy. Sialoendoscopy can significantly alleviate the clinical symptoms, which is an effective therapy, and better for early lesions.

Key words: Sialoendoscopy, Sialadenitis, Iodine radioisotopes, Diagnosis, Treatment outcome

中图分类号:

R781.7

李潇,苏家增,张严妍,张丽琪,张亚琼,柳登高,俞光岩. ¹³¹I相关唾液腺炎的炎症分级及内镜治疗[J]. 北京大学学报（医学版）, 2020, 52(3): 586-590.

Xiao LI,Jia-zeng SU,Yan-yan ZHANG,Li-qi ZHANG,Ya-qiong ZHANG,Deng-gao LIU,Guang-yan YU. Inflammation grading and sialoendoscopic treatment of¹³¹I radioiodine-induced sialadenitis[J]. Journal of Peking University (Health Sciences), 2020, 52(3): 586-590.

图/表 2

图1

图2

参考文献 20

[1]	van Nostrand D. The benefits and risks of I-131 therapy in patients with well-differentiated thyroid cancer[J]. Thyroid, 2009,19(12):1381-1391.
[2]	Lu L, Shan F, Li W, et al. Short-term side effects after radioiodine treatment in patients with differentiated thyroid cancer[J]. Biomed Res Int, 2016,2016(9):1-5.
[3]	De Luca R, Vicidomini A, Trodella M, et al. Sialoendoscopy: A viable treatment for I¹³¹ induced sialoadenitis [J]. Br J Oral Maxillofac Surg, 2014,52(7):641-646.
[4]	柳登高, 郭玉娇, 姜岚, 等. 43例慢性阻塞性腮腺炎内镜治疗疗效观察[J]. 中华口腔医学杂志, 2012,47(9):81-84.
[5]	Ish-Shalom S, Durleshter L, Segal E, et al. Sialochemical and oxidative analyses in radioactive¹³¹I-treated patients with thyroid carcinoma [J]. Eur J Endocrinol, 2008,158(5):677-681.
[6]	Badam RK, Suram J, Babu DB, et al. Assessment of salivary gland function using salivary scintigraphy in pre and post radioactive iodine therapy in diagnosed thyroid carcinoma patients[J]. J Clin Diagn Res, 2016,10(1):60-62.
[7]	Ali MJ. Iodine-131 therapy and nasolacrimal duct obstructions: What we know and what we need to know[J]. Ophthalmic Plast Reconstr Surg, 2016,32(4):243-248.
[8]	Maruoka Y, Baba S, Isoda T, et al. A functional scoring system based on salivary gland scintigraphy for evaluating salivary gland dysfunction secondary to ¹³¹I therapy in patients with differentiated thyroid carcinoma [J]. J Clin Diagn Res, 2017, 11(8): TC23-TC28.
[9]	Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review[J]. Endocr Relat Cancer, 2005,12(4):773-803. pmid: 16322322
[10]	Wu CB, Xi H, Zhou Q, et al. Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis[J]. J Oral Maxillofac Surg, 2015,73(3):475-481.
[11]	Allweiss P, Braunstein GD, Katz A, et al. Sialadenitis following¹³¹I therapy for thyroid carcinoma: Concise communication [J]. J Nucl Med, 1984,25(7):755-758. pmid: 6737074
[12]	Silberstein EB. Reducing the incidence of¹³¹I-induced sialadenitis: the role of pilocarpine [J]. J Nucl Med, 2008,49(4):546-549. doi: 10.2967/jnumed.107.049411 pmid: 18344428
[13]	Ko KY, Kao CH, Lin CL, et al. ¹³¹I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: A nationwide population-based cohort study [J]. Eur J Nucl Med Mol Imag, 2015,42(8):1172-1178.
[14]	Chow S. Side effects of high-dose radioactive iodine for ablation or treatment of differentiated thyroid carcinoma[J]. J HK Coll Radiol, 2005(8):127-135.
[15]	Malpani BL, Samuel AM, Ray S. Quantification of salivary gland function in thyroid cancer patients treated with radioiodine[J]. Int J Radiat Oncol Biol Phys, 1996,35(3):535-540. pmid: 8655377
[16]	Geres AE, Mereshian PS, Fernández S, et al. Sialadenitis after radioiodine therapy: Analysis of factors that influence the response to medical treatment[J]. Endocrinol Nutr, 2015,62(10):493-498. pmid: 26459118
[17]	Wu JQ, Feng HJ, Ouyang W, et al. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up[J]. Nucl Med Commun, 2015,36(8):819. doi: 10.1097/MNM.0000000000000325 pmid: 25932534
[18]	Nahlieli O, Nazarian Y. Sialadenitis following radioiodine therapy a new diagnostic and treatment modality[J]. Oral Disease, 2006,12(5):476-479.
[19]	Gonzalez ME, Muttikkal TJ, Rehm PK. Sialadenitis following low dose I-131 diagnostic thyroid scan with Thyrogen^® (recombinant human thyroid stimulating hormone-thyrotropin alfa) [J]. J Radiol Case Rep, 2015,9(6):44-49. pmid: 26622936
[20]	Prendes BL, Orloff LA, Eisele DW. Therapeutic sialendoscopy for the management of radioiodine sialadenitis[J]. Arch Otolaryngol Head Neck Surg, 2012,138(1):15-19.

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed

¹³¹I相关唾液腺炎的炎症分级及内镜治疗

Inflammation grading and sialoendoscopic treatment of¹³¹I radioiodine-induced sialadenitis

RICH HTML

PDF (PC)

摘要/Abstract

引用本文

使用本文

图/表 2

参考文献 20

相关文章 15

Metrics

本文评价

推荐阅读 10

[1]	俞光岩,柳登高,李巍,洪霞,张严妍,朱文瑄,张可夫,李潇,栗占国,刘燕鹰,陈艳,高岩,苏家增. 3类新型慢性唾液腺炎的诊断和治疗[J]. 北京大学学报（医学版）, 2022, 54(1): 13-17.
[2]	李伟浩,李伟,张学民,李清乐,焦洋,张韬,蒋京军,张小明. 去分支杂交手术和传统手术治疗胸腹主动脉瘤的结果比较[J]. 北京大学学报（医学版）, 2022, 54(1): 177-181.
[3]	孟广艳,张筠肖,张渝昕,刘燕鹰. IgG4相关性疾病中枢神经系统受累的临床特点分析[J]. 北京大学学报（医学版）, 2021, 53(6): 1043-1048.
[4]	翟莉,邱楠,宋惠. 多中心网状组织细胞增生症1例[J]. 北京大学学报（医学版）, 2021, 53(6): 1183-1187.
[5]	朱正达,高岩,何汶秀,方鑫,刘洋,魏攀,闫志敏,华红. 红色诺卡氏菌细胞壁骨架治疗糜烂型口腔扁平苔藓的疗效及安全性[J]. 北京大学学报（医学版）, 2021, 53(5): 964-969.
[6]	邱敏,费月阳,邓绍晖,刘承,卢剑,何为,陆敏,田晓军,张树栋,马潞林. 后肾腺瘤的诊治经验及文献回顾[J]. 北京大学学报（医学版）, 2021, 53(2): 417-419.
[7]	孟圆,张丽琪,赵雅宁,柳登高,张祖燕,高岩. 67例上颌根尖周囊肿的三维影像特点分析[J]. 北京大学学报（医学版）, 2021, 53(2): 396-401.
[8]	王昱,邓雪蓉,季兰岚,张晓慧,耿研,张卓莉. 超声检测痛风患者肌腱受累的危险因素和诊断价值[J]. 北京大学学报（医学版）, 2021, 53(1): 143-149.
[9]	俞光岩. 多发性唾液腺肿大的鉴别诊断及处理[J]. 北京大学学报（医学版）, 2021, 53(1): 1-4.
[10]	高璐,谷岩. 中国人群腭中缝形态特点分期与Demirjian牙龄的相关性[J]. 北京大学学报（医学版）, 2021, 53(1): 133-138.
[11]	袁源,郎宁,袁慧书. CT能谱曲线在脊柱转移瘤和感染性病变中的鉴别诊断价值[J]. 北京大学学报（医学版）, 2021, 53(1): 183-187.
[12]	贾园,栗占国. 成人巨噬细胞活化综合征诊断困境和个体化治疗[J]. 北京大学学报（医学版）, 2020, 52(6): 991-994.
[13]	康琦,张继新,高莹,张俊清,郭晓蕙. 100例甲状腺嗜酸细胞腺瘤的诊治分析[J]. 北京大学学报（医学版）, 2020, 52(6): 1098-1101.
[14]	程功,张霞,杨菲,程嘉渝,刘燕鹰. 以发热、关节炎、皮肤色素沉着为主要表现的血管免疫母细胞性T细胞淋巴瘤1例[J]. 北京大学学报（医学版）, 2020, 52(6): 1150-1152.
[15]	赵冬慧,李丹阳,张帆,屈磊,张颖,王素霞,刘刚. 4例重链或轻重链肾淀粉样变性患者的临床病理特点[J]. 北京大学学报（医学版）, 2020, 52(6): 1162-1165.